Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.305 HKD | 0.00% | -1.61% | -69.19% |
Sales 2023 * | 76.95M 10.65M 83.35M | Sales 2024 * | 135M 18.71M 146M | Capitalization | 120M 16.57M 130M |
---|---|---|---|---|---|
Net income 2023 * | -419M -57.99M -454M | Net income 2024 * | -365M -50.51M -395M | EV / Sales 2023 * | -1.43 x |
Net cash position 2023 * | 230M 31.85M 249M | Net cash position 2024 * | 510M 70.57M 552M | EV / Sales 2024 * | -2.89 x |
P/E ratio 2023 * |
-0.28
x | P/E ratio 2024 * |
-0.33
x | Employees | 118 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.49% |
Latest transcript on CANbridge Pharmaceuticals Inc.
1 week | -1.61% | ||
Current month | -27.38% | ||
1 month | -27.38% | ||
3 months | -69.50% | ||
6 months | -77.57% | ||
Current year | -69.19% |
Managers | Title | Age | Since |
---|---|---|---|
James Xue
CEO | Chief Executive Officer | 55 | 18-01-29 |
Glenn Hassan
DFI | Director of Finance/CFO | 46 | 19-04-01 |
Gerald Cox
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Hu
BRD | Director/Board Member | 61 | 22-07-04 |
James Geraghty
BRD | Director/Board Member | 70 | 18-07-17 |
Peng Kuan Chan
BRD | Director/Board Member | 61 | 21-06-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.305 | 0.00% | 96 000 |
24-03-27 | 0.305 | 0.00% | 14,000 |
24-03-26 | 0.305 | 0.00% | 8,000 |
24-03-25 | 0.305 | 0.00% | 7,000 |
24-03-22 | 0.305 | -4.69% | 43,000 |
Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-69.19% | 16.56M | |
+14.56% | 9.82B | |
-7.87% | 5.49B | |
+12.50% | 4.21B | |
+18.09% | 3.66B | |
+42.95% | 2.93B | |
-19.01% | 2.54B | |
-20.66% | 2.35B | |
+16.14% | 1.85B | |
-0.50% | 1.64B |